| Quarterly Financials | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 166 | 249 | 271 | 255 | 219 | 243 | 321 | 315 | 326 | 295 | 341 | 345 | 354 | 342 | 429 | 411 | 385 | 373 | 453 |
| Expenses | 132 | 168 | 177 | 160 | 164 | 155 | 204 | 200 | 219 | 200 | 215 | 218 | 236 | 237 | 270 | 264 | 255 | 249 | 296 |
| EBITDA | 34 | 80 | 94 | 95 | 54 | 88 | 117 | 115 | 107 | 96 | 125 | 127 | 118 | 106 | 158 | 148 | 129 | 124 | 157 |
| Operating Profit % | 20 % | 32 % | 34 % | 36 % | 23 % | 35 % | 35 % | 35 % | 31 % | 31 % | 35 % | 35 % | 31 % | 28 % | 35 % | 34 % | 31 % | 29 % | 33 % |
| Depreciation | 20 | 19 | 21 | 21 | 22 | 22 | 23 | 23 | 23 | 25 | 27 | 28 | 32 | 34 | 35 | 35 | 34 | 34 | 36 |
| Interest | 13 | 13 | 12 | 12 | 16 | 14 | 13 | 14 | 14 | 15 | 13 | 14 | 17 | 18 | 18 | 18 | 18 | 18 | 19 |
| Profit Before Tax | 2 | 48 | 61 | 62 | 16 | 52 | 81 | 78 | 70 | 56 | 85 | 85 | 69 | 53 | 105 | 94 | 77 | 71 | 102 |
| Tax | 1 | 12 | 16 | 17 | 4 | 13 | 20 | 20 | 16 | 14 | 22 | 22 | 18 | 14 | 26 | 25 | 20 | 18 | 27 |
| Net Profit | 1 | 36 | 45 | 45 | 12 | 39 | 62 | 58 | 54 | 42 | 63 | 63 | 51 | 40 | 79 | 69 | 57 | 54 | 76 |
| EPS in ₹ | 0.14 | 3.91 | 4.87 | 4.79 | 1.36 | 3.78 | 6.06 | 5.74 | 5.31 | 4.04 | 6.20 | 6.12 | 5.02 | 3.89 | 7.77 | 6.76 | 5.55 | 5.27 | 7.41 |
Rainbow Childrens Medicare
Rainbow Childrens Medicare
1,351.30
-5.40
(-0.40%)
Market Cap
₹13,723.69 Cr
PE Ratio
53.31
Volume
90,585.00
Day High - Low
₹1,366.00 - ₹1,332.00
52W High-Low
₹1,706.00 - ₹1,218.00
Key Fundamentals
Market Cap
13,723.69 Cr
EPS
23.97
PB Ratio
8.95
Book Value
149.46
EBITDA
540.90
Dividend Yield
0.22 %
Industry
Healthcare Services Sector
Hospitals ROE Growth %
-
Debt to Equity
0.56
Analyst Rating and Forecast
- By Refinitiv from9 analysts
Actual
Company News
View All News
Rainbow Children's Medicare Reports 6.5% Revenue Growth Despite Seasonal Headwinds in Q2 FY26
8 days ago
8 days agoRainbow Children's Medicare achieved revenue of Rs 444.8 crores with 6.5% growth and EBITDA of Rs 148.8 crores despite lower occupancy rates due to reduced seasonal illnesses and early festive season impact. The company completed acquisitions of Prashanthi Hospital in Warangal and Pratiksha Hospital in Guwahati, appointed Abrarali Dalal as Group CEO effective January 2026, and targets 20% revenue growth over the next two years with ongoing expansion plans.
Rainbow Children's Medicare Limited's Nomination and Remuneration Committee granted 5,660 stock options to eligible employees under the Employee Stock Option Scheme 2025 on November 13, 2025. The options are exercisable at a discount of up to 20% from the November 12, 2025 NSE closing price, with vesting period ranging from 1 to 10 years and exercise window of 2 years from vesting date.
Rainbow Children's Medicare achieved revenue of ₹4,448 million in Q2FY26, up 6.5% from ₹4,175 million in Q2FY25, with EBITDA rising to ₹1,489 million and PAT reaching ₹756 million. The pediatric healthcare chain expanded its network to 22 hospitals across 9 cities with 2,285 beds, including recent acquisitions of Prashanthi Hospital in Warangal and Pratiksha Hospital in Guwahati.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,162.80 | #1 1,13,051.65 | 83.67 | 7,184.10 | #1 28.65 | 1,076 | #1 74.34 | 54.18 | |
7,335.50 | 1,05,473.24 | 61.72 | #1 21,994.30 | 14.76 | #1 1,505 | 24.84 | 36.28 | |
919.10 | 69,388.20 | 68.04 | 7,849.70 | 13.25 | 809 | 70.27 | 33.39 | |
1,945.50 | 39,758.39 | 48.80 | 5,575.00 | 12.29 | 790 | 30.03 | 57.74 | |
665.45 | 34,478.36 | 94.45 | 4,286.70 | 15.12 | 337 | 14.65 | 45.83 | |
1,246.00 | 33,491.28 | 58.06 | 3,771.40 | 12.59 | 481 | 21.10 | 47.27 | |
685.10 | 27,413.52 | 75.73 | 3,067.00 | 21.98 | 415 | -40.35 | 46.53 | |
533.75 | 16,874.95 | 107.45 | 1,757.00 | 27.64 | 110 | 71.36 | 62.47 | |
5,986.90 | 15,278.08 | #1 28.77 | 599.90 | 11.69 | 58 | 16.17 | 35.67 | |
1,351.30 | #10 13,723.69 | #3 53.31 | #9 1,566.90 | #4 17.46 | #8 244 | #9 -4.30 | 49.40 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
17.46 %
Net Income Growth
11.86 %
Cash Flow Change
23.11 %
ROE
-4.06 %
ROCE
3.26 %
EBITDA Margin (Avg.)
-1.17 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,776 | 2,170 | 2,377 |
| Fixed Assets | 78 | 123 | 174 | 296 | 702 | 702 | 772 | 858 | 931 | 1,253 | 1,398 |
| Current Assets | 98 | 171 | 125 | 73 | 133 | 203 | 197 | 290 | 484 | 622 | 822 |
| Capital Work in Progress | 35 | 31 | 7 | 12 | 23 | 43 | 29 | 6 | 23 | 20 | 29 |
| Investments | 7 | 2 | 6 | 0 | 3 | 10 | 18 | 22 | 58 | 308 | 571 |
| Other Assets | 111 | 194 | 212 | 140 | 199 | 265 | 262 | 409 | 764 | 590 | 380 |
| Total Liabilities | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,776 | 2,170 | 2,377 |
| Current Liabilities | 36 | 42 | 56 | 71 | 92 | 130 | 122 | 125 | 144 | 150 | 151 |
| Non Current Liabilities | 15 | 13 | 14 | 15 | 463 | 480 | 511 | 564 | 567 | 756 | 751 |
| Total Equity | 181 | 295 | 329 | 362 | 372 | 409 | 448 | 606 | 1,065 | 1,265 | 1,475 |
| Reserve & Surplus | 166 | 275 | 309 | 307 | 317 | 351 | 392 | 498 | 958 | 1,157 | 1,367 |
| Share Capital | 15 | 20 | 20 | 55 | 55 | 55 | 55 | 105 | 102 | 102 | 102 |
Cash Flow
| Cash Flow | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | -1 | 3 | 1 | -2 | 2 | 2 | -1 | 4 | 5 | -7 | 10 |
| Investing Activities | -113 | -20 | -107 | -33 | -42 | -117 | -117 | -83 | -175 | -465 | -227 | -268 |
| Operating Activities | 15 | 26 | 17 | 36 | 48 | 127 | 170 | 143 | 224 | 327 | 321 | 396 |
| Financing Activities | 98 | -7 | 93 | -1 | -8 | -9 | -52 | -61 | -44 | 143 | -102 | -118 |
Share Holding
| % Holding | Dec 2021 | May 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 63.70 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.88 % | 49.85 % | 49.85 % | 49.85 % | 49.85 % | 49.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 21.63 % | 22.32 % | 24.04 % | 24.78 % | 25.11 % | 25.12 % | 23.69 % | 23.59 % | 21.85 % |
| DIIs | 0.00 % | 6.35 % | 6.55 % | 10.26 % | 13.90 % | 15.38 % | 15.35 % | 15.40 % | 15.62 % | 14.76 % | 13.80 % | 13.83 % | 13.87 % | 15.31 % | 15.44 % | 17.46 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 19.03 % | 15.87 % | 13.24 % | 13.75 % | 13.29 % | 13.04 % | 11.92 % | 11.03 % | 10.40 % | 10.74 % | 10.40 % | 10.38 % | 10.34 % | 10.32 % | 10.06 % |
| Others | 36.30 % | 24.79 % | 27.75 % | 26.67 % | 22.52 % | 21.50 % | 21.78 % | 1.22 % | 1.21 % | 0.97 % | 0.80 % | 0.80 % | 0.77 % | 0.79 % | 0.79 % | 0.78 % |
| No of Share Holders | 146 | 2,43,189 | 1,66,064 | 91,530 | 79,224 | 75,611 | 74,690 | 79,187 | 80,471 | 77,152 | 78,557 | 77,524 | 78,764 | 79,092 | 80,320 | 81,134 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2 | 3 | 3 | 3 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.23 | 0.21 | 0.22 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2022 |  Dividend | ₹ 2.00 /share | 07 Sept 2022 | 489.05 | 611.60 |
| 22 Jun 2023 | Dividend | ₹ 3.00 /share | 22 Jun 2023 | 849.65 | 977.25 |
| 23 Jul 2024 | Dividend | ₹ 3.00 /share | 23 Jul 2024 | 1,393.75 | 1,145.75 |
| 30 Jul 2024 |  Annual General Meeting | NA | 30 Jul 2024 | 1,393.75 | 1,172.30 |
| 27 Oct 2024 |  Quarterly Result Announcement | NA | 27 Oct 2024 | 1,431.30 | 1,417.75 |
| 09 Feb 2025 | Quarterly Result Announcement | NA | 09 Feb 2025 | 1,423.75 | 1,383.95 |
| 24 May 2025 | Quarterly Result Announcement | NA | 24 May 2025 | 1,366.75 | 1,352.30 |
| 28 Jun 2025 | Dividend | ₹ 3.00 /share | 27 Jun 2025 | 1,352.30 | 1,512.95 |
| 05 Jul 2025 | Annual General Meeting | NA | 05 Jul 2025 | 1,352.30 | 1,599.40 |
| 26 Jul 2025 | Quarterly Result Announcement | NA | 26 Jul 2025 | 1,526.50 | 1,554.50 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 1,363.70 | 1,359.10 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 13, 2025
Nov 13, 2025Grant Of Stock OptionsNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 13, 2025
Nov 13, 2025Unaudited Financial Results Quarter And Half Year Ended September 30 2025Nov 13, 2025
Nov 13, 2025Board Meeting Outcome for Outcome For The Board Meeting Held On November 13 2025Nov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 08, 2025
Nov 08, 2025Board Meeting Intimation for Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.Nov 07, 2025
Nov 07, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 13, 2025
Sep 13, 2025Commencement Of A New Spoke Hospital In Rajahmundry Andhra Pradesh.Sep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Aug 29, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-AcquisitionAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 26, 2025
Jul 26, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 26, 2025
Jul 26, 2025Grant Of Stock OptionsJul 26, 2025
Jul 26, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 26, 2025
Jul 26, 2025Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On July 26 2025Jul 26, 2025
Jul 26, 2025Unaudited Financial Results For The Quarter Ended June 30 2025Jul 26, 2025
Jul 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 22, 2025
Jul 22, 2025Board Meeting Intimation for Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30 2025.Jul 21, 2025
Jul 21, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 07, 2025
Jul 07, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 05, 2025
Jul 05, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 01, 2025
Jul 01, 2025Announcement under Regulation 30 (LODR)-AcquisitionJun 28, 2025
Jun 28, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 21, 2025
Jun 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 14, 2025
Jun 14, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 13, 2025
Jun 13, 2025Business Responsibility and Sustainability Reporting (BRSR)Jun 13, 2025
Jun 13, 2025Reg. 34 (1) Annual Report.Jun 13, 2025
Jun 13, 2025Notice Of 27Th Annual General Meeting To Be Held On July 5 2025Jun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 07, 2025
Jun 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Jun 03, 2025Mutual Fund Holdings
ICICI Prudential Large & Mid Cap Fund Direct Plan-Growth 
SBI Innovative Opportunities Fund Direct-Growth 
Bandhan Flexi Cap Fund Direct-Growth 
Aditya Birla Sun Life Bal Bhavishya Yojna Direct-Growth 
NJ ELSS Tax Saver Scheme Direct - Growth 
Tata ELSS Fund Direct-Growth 
Shriram Multi Sector Rotation Fund Direct-Growth 
PGIM India Small Cap Fund Direct - Growth 
Baroda BNP Paribas Health and Wellness Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 51.13
ATR(14)
Less Volatile 31.02
STOCH(9,6)
Neutral 75.64
STOCH RSI(14)
Overbought 95.61
MACD(12,26)
Bullish 2.73
ADX(14)
Weak Trend 17.39
UO(9)
Bearish 69.26
ROC(12)
Uptrend And Accelerating 0.12
WillR(14)
Neutral -28.65
About Rainbow Childrens Medicare
Rainbow Children's Medicare Limited is a leading chain of multi-specialty pediatric, obstetrics, and gynecology hospitals in India. Originally incorporated in 1998, it operates 16 hospitals and three clinics across six cities, with a total bed capacity of 1,655. The company specializes in pediatric services, including newborn and pediatric intensive care, multi-specialty services, and quaternary care, as well as obstetrics and gynecology services. Founded by Dr. Ramesh Kancharla, Rainbow follows a full-time, exclusive doctor-led model of healthcare delivery. The company expanded its services over the years, establishing hospitals in various cities and introducing new specialties. In 2022, Rainbow completed an Initial Public Offering and its shares were listed on the National Stock Exchange of India Limited and BSE Limited. The company also offers post-graduate DNB and fellowship programs in pediatrics.
Listing Date
10 May, 2022(3 Years,
19 days)
Chairperson NameRamesh Kancharla
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
